|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV052833461 |
003 |
DE-627 |
005 |
20230624190242.0 |
007 |
cr uuu---uuuuu |
008 |
210910s2021 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.earlhumdev.2020.105303
|2 doi
|
028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001281.pica
|
035 |
|
|
|a (DE-627)ELV052833461
|
035 |
|
|
|a (ELSEVIER)S0378-3782(20)30807-0
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a Cabon, S.
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Voxyvi: A system for long-term audio and video acquisitions in neonatal intensive care units
|
264 |
|
1 |
|c 2021
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a In the European Union, 300,000 newborn babies are born prematurely every year. Their care is ensured in Neonatal Intensive Care Units (NICU) where vital signs are constantly monitored. In addition, other descriptors such as motion, facial and vocal activities have been shown to be essential to assess neurobehavioral development.
|
700 |
1 |
|
|a Porée, F.
|4 oth
|
700 |
1 |
|
|a Cuffel, G.
|4 oth
|
700 |
1 |
|
|a Rosec, O.
|4 oth
|
700 |
1 |
|
|a Geslin, F.
|4 oth
|
700 |
1 |
|
|a Pladys, P.
|4 oth
|
700 |
1 |
|
|a Simon, A.
|4 oth
|
700 |
1 |
|
|a Carrault, G.
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:153
|g year:2021
|g pages:0
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2020.105303
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 153
|j 2021
|h 0
|